Search

Home > GRACEcast Lung Cancer Video > What is the Role of Immunotherapy for Patients with Advanced NSCLC and a Driver Mutation?
Podcast: GRACEcast Lung Cancer Video
Episode:

What is the Role of Immunotherapy for Patients with Advanced NSCLC and a Driver Mutation?
Category: Science & Medicine
Duration: 00:20:05
Publish Date: 2015-12-18 14:00:00
Description:

Dr. Greg Riely from Memorial Sloan-Kettering Cancer Center reviews the limited data that help clarify the probability of benefit from new immunotherapy agents among patients with advanced NSCLC and an identified driver mutation.
Total Play: 0